GENE ONLINE|News &
Opinion
Blog

2021-02-21| IPOSpecial

BIOCEO21 Highlights: Criteria for Successful Launches of Biotech SPACs

by Daniel Ojeda
Share To
When a company enters the stock market, it allows the public to trade its shares. An Initial Public Offering (IPO) allows companies to offer new stocks to the investors and raise capital. Well-funded companies can do a direct listing, which allows them to sell existing shares and avoid the cost of a traditional IPO. However, it doesn’t let them raise more capital. Over the last few years, Special Purpose Acquisition Company (SPAC) has become a more popular route to IPO.

It's free! Log in now to read

LATEST
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
EVENT
Scroll to Top